JP2012522044A - ジペプチジルペプチダーゼ−iv阻害剤及び中間体の改良された製造方法 - Google Patents
ジペプチジルペプチダーゼ−iv阻害剤及び中間体の改良された製造方法 Download PDFInfo
- Publication number
- JP2012522044A JP2012522044A JP2012503324A JP2012503324A JP2012522044A JP 2012522044 A JP2012522044 A JP 2012522044A JP 2012503324 A JP2012503324 A JP 2012503324A JP 2012503324 A JP2012503324 A JP 2012503324A JP 2012522044 A JP2012522044 A JP 2012522044A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- chemical formula
- producing
- protecting group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940124213 Dipeptidyl peptidase 4 (DPP IV) inhibitor Drugs 0.000 title claims abstract description 21
- 239000003603 dipeptidyl peptidase IV inhibitor Substances 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims description 26
- 238000002360 preparation method Methods 0.000 title claims description 14
- 239000000543 intermediate Substances 0.000 title abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 57
- 238000006243 chemical reaction Methods 0.000 claims abstract description 56
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims description 108
- 239000000126 substance Substances 0.000 claims description 61
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 33
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 28
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- -1 9-fluorenylmethoxycarbonyl Chemical group 0.000 claims description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 23
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 16
- 125000006239 protecting group Chemical group 0.000 claims description 12
- 125000006242 amine protecting group Chemical group 0.000 claims description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 8
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 8
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 8
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 6
- 125000004744 butyloxycarbonyl group Chemical group 0.000 claims description 6
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 4
- 239000007818 Grignard reagent Substances 0.000 claims description 4
- 239000007810 chemical reaction solvent Substances 0.000 claims description 4
- 150000004795 grignard reagents Chemical class 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 238000007363 ring formation reaction Methods 0.000 claims description 4
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 3
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims description 3
- 239000004593 Epoxy Substances 0.000 claims description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 2
- 125000004069 aziridinyl group Chemical group 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- RIVIDPPYRINTTH-UHFFFAOYSA-N n-ethylpropan-2-amine Chemical compound CCNC(C)C RIVIDPPYRINTTH-UHFFFAOYSA-N 0.000 claims description 2
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 37
- 238000005481 NMR spectroscopy Methods 0.000 description 18
- 239000000203 mixture Substances 0.000 description 13
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 11
- 239000012044 organic layer Substances 0.000 description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 description 9
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 8
- 229910052938 sodium sulfate Inorganic materials 0.000 description 8
- 235000011152 sodium sulphate Nutrition 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000001914 filtration Methods 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 6
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 125000003277 amino group Chemical group 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- LCDDAGSJHKEABN-MLGOLLRUSA-N Evogliptin Chemical compound C1CNC(=O)[C@@H](COC(C)(C)C)N1C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F LCDDAGSJHKEABN-MLGOLLRUSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- LCZHEYSGJREGGL-SSDOTTSWSA-N (3r)-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one Chemical compound CC(C)(C)OC[C@H]1NCCNC1=O LCZHEYSGJREGGL-SSDOTTSWSA-N 0.000 description 3
- HHMADUNKNVWYFC-UHFFFAOYSA-N 1-azido-3-(2,4,5-trifluorophenyl)propan-2-ol Chemical compound [N-]=[N+]=NCC(O)CC1=CC(F)=C(F)C=C1F HHMADUNKNVWYFC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 3
- MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- HHMADUNKNVWYFC-LURJTMIESA-N (2s)-1-azido-3-(2,4,5-trifluorophenyl)propan-2-ol Chemical compound [N-]=[N+]=NC[C@@H](O)CC1=CC(F)=C(F)C=C1F HHMADUNKNVWYFC-LURJTMIESA-N 0.000 description 2
- TUAXCHGULMWHIO-SECBINFHSA-N (3r)-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-(2,4,5-trifluorophenyl)butanoic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CC(O)=O)CC1=CC(F)=C(F)C=C1F TUAXCHGULMWHIO-SECBINFHSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical group C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 2
- YSQLGGQUQDTBSL-UHFFFAOYSA-N 2-(2,4,5-trifluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC(F)=C(F)C=C1F YSQLGGQUQDTBSL-UHFFFAOYSA-N 0.000 description 2
- LFUPRXUCNYXOPO-UHFFFAOYSA-N 2-[(2,4,5-trifluorophenyl)methyl]aziridine Chemical compound C1=C(F)C(F)=CC(F)=C1CC1NC1 LFUPRXUCNYXOPO-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000003377 acid catalyst Substances 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- RLZXKARDPOFVNB-UHFFFAOYSA-N aziridine-1-carboxylic acid Chemical compound OC(=O)N1CC1 RLZXKARDPOFVNB-UHFFFAOYSA-N 0.000 description 2
- SRJSIZMJIPBTCX-UHFFFAOYSA-N benzyl 2-[(2,4,5-trifluorophenyl)methyl]aziridine-1-carboxylate Chemical compound Fc1cc(F)c(CC2CN2C(=O)OCc2ccccc2)cc1F SRJSIZMJIPBTCX-UHFFFAOYSA-N 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 2
- NQHJWUFRNXYFJD-LURJTMIESA-N methyl (2s)-2-bromo-3-[(2-methylpropan-2-yl)oxy]propanoate Chemical compound COC(=O)[C@@H](Br)COC(C)(C)C NQHJWUFRNXYFJD-LURJTMIESA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229960004034 sitagliptin Drugs 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BRLQWZUYTZBJKN-GSVOUGTGSA-N (+)-Epichlorohydrin Chemical compound ClC[C@@H]1CO1 BRLQWZUYTZBJKN-GSVOUGTGSA-N 0.000 description 1
- PDJQCHVMABBNQW-MIXQCLKLSA-L (1z,5z)-cycloocta-1,5-diene;rhodium;dichloride Chemical compound [Cl-].[Cl-].[Rh].[Rh].C\1C\C=C/CC\C=C/1.C\1C\C=C/CC\C=C/1 PDJQCHVMABBNQW-MIXQCLKLSA-L 0.000 description 1
- YLMKCWZOBGYCIX-UHFFFAOYSA-N (2,4,5-trifluorophenyl) N-butan-2-ylcarbamate Chemical compound FC1=C(C=C(C(=C1)F)F)OC(NC(C)CC)=O YLMKCWZOBGYCIX-UHFFFAOYSA-N 0.000 description 1
- FCFWEOGTZZPCTO-QMMMGPOBSA-N (2s)-3,6-dimethoxy-2-propan-2-yl-2,5-dihydropyrazine Chemical compound COC1=N[C@@H](C(C)C)C(OC)=NC1 FCFWEOGTZZPCTO-QMMMGPOBSA-N 0.000 description 1
- HHEMJGOXMZXTNR-CYBMUJFWSA-N (3r)-3-(phenylmethoxycarbonylamino)-4-(2,4,5-trifluorophenyl)butanoic acid Chemical compound C([C@H](CC(=O)O)NC(=O)OCC=1C=CC=CC=1)C1=CC(F)=C(F)C=C1F HHEMJGOXMZXTNR-CYBMUJFWSA-N 0.000 description 1
- ICEMCUCTLWJVRT-ZIAGYGMSSA-N (3r)-3-amino-1-[(2r)-2-[(2-methylpropan-2-yl)oxymethyl]piperazin-1-yl]-4-(2,4,5-trifluorophenyl)butan-1-one Chemical compound CC(C)(C)OC[C@H]1CNCCN1C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F ICEMCUCTLWJVRT-ZIAGYGMSSA-N 0.000 description 1
- KNTZCGBYFGEMFR-UHFFFAOYSA-N (propan-2-ylazaniumyl)formate Chemical compound CC(C)NC(O)=O KNTZCGBYFGEMFR-UHFFFAOYSA-N 0.000 description 1
- WPYLRLKFINSMTC-UHFFFAOYSA-N 1-(4-methylphenyl)sulfonyl-2-[(2,4,5-trifluorophenyl)methyl]aziridine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C(CC=2C(=CC(F)=C(F)C=2)F)C1 WPYLRLKFINSMTC-UHFFFAOYSA-N 0.000 description 1
- GAUXEYCSWSMMFZ-UHFFFAOYSA-N 1-(bromomethyl)-2,4,5-trifluorobenzene Chemical compound FC1=CC(F)=C(CBr)C=C1F GAUXEYCSWSMMFZ-UHFFFAOYSA-N 0.000 description 1
- DVTULTINXNWGJY-UHFFFAOYSA-N 1-Bromo-2,4,5-trifluorobenzene Chemical compound FC1=CC(F)=C(Br)C=C1F DVTULTINXNWGJY-UHFFFAOYSA-N 0.000 description 1
- HGSHDZDXWONBFS-UHFFFAOYSA-N 1-[2-[(2,4,5-trifluorophenyl)methyl]aziridin-1-yl]ethanone Chemical compound CC(=O)N1CC1CC1=CC(F)=C(F)C=C1F HGSHDZDXWONBFS-UHFFFAOYSA-N 0.000 description 1
- WZLOKEZFZKLWIH-UHFFFAOYSA-N 1-chloro-3-(2,4,5-trifluorophenyl)propan-2-ol Chemical compound ClCC(O)CC1=CC(F)=C(F)C=C1F WZLOKEZFZKLWIH-UHFFFAOYSA-N 0.000 description 1
- GAVMRTMJEVMRGR-UHFFFAOYSA-N 2,3,5,6-tetrahydro-1h-triazolo[4,5-b]pyrazine Chemical group N1CCNC2=C1N=NN2 GAVMRTMJEVMRGR-UHFFFAOYSA-N 0.000 description 1
- SWJFYJHCOWRRLR-UHFFFAOYSA-N 2-azaniumyl-3-(2,4,5-trifluorophenyl)propanoate Chemical compound OC(=O)C(N)CC1=CC(F)=C(F)C=C1F SWJFYJHCOWRRLR-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000024188 Andala Species 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 description 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 101000886298 Pseudoxanthomonas mexicana Dipeptidyl aminopeptidase 4 Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- JIWRAHHCDZUHKY-UHFFFAOYSA-M [Br-].FC1=CC(F)=C([Mg+])C=C1F Chemical compound [Br-].FC1=CC(F)=C([Mg+])C=C1F JIWRAHHCDZUHKY-UHFFFAOYSA-M 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- MJSHDCCLFGOEIK-UHFFFAOYSA-N benzyl (2,5-dioxopyrrolidin-1-yl) carbonate Chemical compound O=C1CCC(=O)N1OC(=O)OCC1=CC=CC=C1 MJSHDCCLFGOEIK-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 150000001576 beta-amino acids Chemical group 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- QCIGLPLDNRDLQQ-UHFFFAOYSA-N butan-2-ylcarbamic acid Chemical compound CCC(C)NC(O)=O QCIGLPLDNRDLQQ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- OIPMLYHGBADVSS-UHFFFAOYSA-N butyl n-(2-oxoethyl)carbamate Chemical compound CCCCOC(=O)NCC=O OIPMLYHGBADVSS-UHFFFAOYSA-N 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000667 effect on insulin Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- IRXSLJNXXZKURP-UHFFFAOYSA-N fluorenylmethyloxycarbonyl chloride Chemical compound C1=CC=C2C(COC(=O)Cl)C3=CC=CC=C3C2=C1 IRXSLJNXXZKURP-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940090473 januvia Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical compound CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- GVXAFLUDYYQGCG-VKHMYHEASA-N methyl (2s)-2-bromo-3-hydroxypropanoate Chemical compound COC(=O)[C@@H](Br)CO GVXAFLUDYYQGCG-VKHMYHEASA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- XYEOALKITRFCJJ-UHFFFAOYSA-N o-benzylhydroxylamine Chemical compound NOCC1=CC=CC=C1 XYEOALKITRFCJJ-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- GEVPUGOOGXGPIO-UHFFFAOYSA-N oxalic acid;dihydrate Chemical compound O.O.OC(=O)C(O)=O GEVPUGOOGXGPIO-UHFFFAOYSA-N 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- LEVJVKGPFAQPOI-UHFFFAOYSA-N phenylmethanone Chemical compound O=[C]C1=CC=CC=C1 LEVJVKGPFAQPOI-UHFFFAOYSA-N 0.000 description 1
- HFNGWVXNSWWIGC-UHFFFAOYSA-N phenylmethoxy carbonochloridate Chemical compound ClC(=O)OOCC1=CC=CC=C1 HFNGWVXNSWWIGC-UHFFFAOYSA-N 0.000 description 1
- IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 description 1
- 238000000711 polarimetry Methods 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- WWTULTKUWBKVGV-UHFFFAOYSA-M potassium;3-methoxy-3-oxopropanoate Chemical compound [K+].COC(=O)CC([O-])=O WWTULTKUWBKVGV-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- CLDWGXZGFUNWKB-UHFFFAOYSA-M silver;benzoate Chemical compound [Ag+].[O-]C(=O)C1=CC=CC=C1 CLDWGXZGFUNWKB-UHFFFAOYSA-M 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000001420 substituted heterocyclic compounds Chemical class 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical group C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/02—Formation of carboxyl groups in compounds containing amino groups, e.g. by oxidation of amino alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/08—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated
- C07C247/10—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
- C07C29/10—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
- C07C29/103—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes of cyclic ethers
- C07C29/106—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes of cyclic ethers of oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
- C07D203/10—Radicals substituted by singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/16—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
- C07D203/18—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
前記工程1で製造した化学式4の化合物のアミン保護基を除去して化学式1の化合物を製造する工程(工程2)を含む、化学式1で表わされるジペプチジルペプチダーゼ−IV阻害剤の改良された製造方法を提供する。
工程a:(S)−1−クロロ−3−(2,4,5−トリフルオロフェニル)プロパン−2−オール(化学式6)の製造
250mlのフラスコに、1−ブロモ−2,4,5−トリフルオロベンゼン84.4gとテトラヒドロフラン42.1mlを入れて反応液を−15〜20℃に冷却した。窒素雰囲気下で反応液にイソプロピルマグネシウムクロライド[2.0Mテトラヒドロフラン溶液]20mlを滴下して、0〜5℃で2時間撹拌してグリニャール試薬を製造した。また異なる250mlのフラスコに、(S)−エピクロロヒドリン31.6mlとテトラヒドロフラン42.1mlを入れて反応液を−15〜−20℃に冷却した後、ヨウ化銅7.6gを投入した。窒素雰囲気下で製造したグリニャール試薬42.1mlを滴下して、反応温度を−15〜−20℃に維持しながら3時間撹拌した。反応液に0〜5℃に冷却した2N塩酸水溶液297mlを滴下してイソプロピルエーテル297mlで抽出した。有機層を硫酸ナトリウムで脱水乾燥した後、減圧濃縮して標題の化合物89.8gを得た。
2lのフラスコに前記工程aで製造した(S)−1−クロロ−3−(2,4,5−トリフルオロフェニル)プロパン−2−オール89.9gを入れてジメチルホルムアルデヒド898mlに溶解した後、ヨウ化ナトリウム6.0g、アジ化ナトリウム52.0gを加えて反応液を70℃に昇温させた後、16時間の間撹拌した。反応完了後、反応液を室温に冷却した後、イソプロピルエーテル898mlと水898mlを投入して10分間撹拌した。有機層を分離して1N塩酸水溶液と飽和炭酸水素ナトリウム水溶液で順番に洗浄した後、硫酸ナトリウムで脱水乾燥した後、減圧濃縮して標題の化合物75.4gを得た。
<工程c−1>(R)−t−ブチル 2−(2,4,5−トリフルオロベンジル)アジリジン−1−カルボキシラート(化学式8)の製造
1lのフラスコに前記工程bで製造した(S)−1−アジド−3−(2,4,5−トリフルオロフェニル)プロパン−2−オール18.9gをアセトニトリル188mlに溶解した後、トリフェニルホスフィン21.4gを投入した。常温で1.5時間さらに撹拌した後、70℃に昇温して12時間の間撹拌した。反応液を室温に冷却し、4−ジメチルアミノピリジン1.0gとジ−t−ブチルジカーボネート17.8gを投入して2時間の間撹拌した。反応完了後、過酸化水素0.91gを投入して1時間撹拌した後、減圧濃縮した。濃縮残渣にn−ヘキサン180mlを投入して1時間の間撹拌した。生成された固体をろ過して除去し、ろ過液を減圧濃縮して標題の化合物20.0gを得た。
500mlのフラスコに前記工程bで製造した(S)−1−アジド−3−(2,4,5−トリフルオロフェニル)プロパン−2−オール12.83gをアセトニトリル130mlに溶解した後、トリフェニルホスフィン14.56gを投入した。常温で1.5時間さらに撹拌した後、70℃に昇温して21時間の間撹拌した。反応液を0〜5℃に冷却し、トリエチルアミン6.74gとベンジルオキシクロロホルマート9.47gを投入して1時間の間撹拌した。反応完了後、過酸化水素0.63gを投入して1時間撹拌した後、減圧濃縮した。濃縮残渣にイソプロピルエーテル130mlを投入して1時間の間撹拌した。生成された固体をろ過して除去し、ろ過液を減圧濃縮した。残渣をカラムクロマトグラフィーで精製して標題の化合物15.78gを得た。
500mlのフラスコに前記工程bで製造した(S)−1−アジド−3−(2,4,5−トリフルオロフェニル)プロパン−2−オール7.97gをアセトニトリル80mlに溶解した後、トリフェニルホスフィン9.05gを投入した。常温で1.5時間さらに撹拌した後、70℃に昇温して20時間の間撹拌した。反応液を室温に冷却し、N,N−ジイソプロピルエチルアミン5.35gと4−ジメチルアミノピリジン0.43g、アセチルクロライド3.0gを投入して2時間の間撹拌した。反応完了後、過酸化水素0.4gを投入して1時間撹拌した後、減圧濃縮した。濃縮残渣にn−ヘキサン40mlを投入して1時間の間撹拌した。生成された固体をろ過して除去し、ろ過液を減圧濃縮した。残渣をカラムクロマトグラフィーで精製して標題の化合物4.74gを得た。
500mlのフラスコに前記工程bで製造した(S)−1−アジド−3−(2,4,5−トリフルオロフェニル)プロパン−2−オール7.97gをアセトニトリル80mlに溶解した後、トリフェニルホスフィン9.05gを投入した。常温で1.5時間さらに撹拌した後、70℃に昇温して21時間の間撹拌した。反応液を室温に冷却し、N,N−ジイソプロピルエチルアミン5.35gと4−ジメチルアミノピリジン0.43g、ベンゾイルクロライド5.34gを投入して2時間の間撹拌した。反応完了後、過酸化水素0.4gを投入して1時間撹拌した後、減圧濃縮した。濃縮残渣にn−ヘキサン40mlを投入して1時間の間撹拌した。生成された固体をろ過して除去し、ろ過液を減圧濃縮した。残渣をカラムクロマトグラフィーで精製して標題の化合物7.03gを得た。
500mlのフラスコに前記工程bで製造した(S)−1−アジド−3−(2,4,5−トリフルオロフェニル)プロパン−2−オール7.97gをアセトニトリル80mlに溶解した後、トリフェニルホスフィン9.05gを投入した。常温で1.5時間さらに撹拌した後、70℃に昇温して20時間の間撹拌した。反応液を室温に冷却し、N,N−ジイソプロピルエチルアミン5.35gと4−ジメチルアミノピリジン0.43g、9−フルオレンイルメトキシカルボニルクロライド12.81gを投入して2時間の間撹拌した。反応完了後、過酸化水素0.4gを投入して1時間撹拌した後、減圧濃縮した。濃縮残渣にn−ヘキサン40mlを投入して1時間の間撹拌した。生成された固体をろ過して除去し、ろ過液を減圧濃縮した。残渣をカラムクロマトグラフィーで精製して標題の化合物10.03gを得た。
500mlのフラスコに前記工程bで製造した(S)−1−アジド−3−(2,4,5−トリフルオロフェニル)プロパン−2−オール7.97gをアセトニトリル80mlに溶解した後、トリフェニルホスフィン9.05gを投入した。常温で1.5時間さらに撹拌した後、70℃に昇温して20時間の間撹拌した。反応液を0〜5℃に冷却し、N,N−ジイソプロピルエチルアミン5.35gとトシルクロライド7.24gを投入して2時間の間撹拌した後、減圧濃縮した。濃縮残渣にイソプロピルエーテル40mlを投入して1時間の間撹拌した。生成された固体をろ過して除去し、ろ過液を減圧濃縮した。残渣をカラムクロマトグラフィーで精製して標題の化合物7.07gを得た。
<工程d−1>(R)−t−ブチル 1−シアノ−3−(2,4,5−トリフルオロフェニル)プロパン−2−イルカルバメート(化学式9)の製造
250mlのフラスコに前記工程c−1で製造した(R)−t−ブチル 2−(2,4,5−トリフルオロベンジル)アジリジン−1−カルボキシラート6.7gをジメチルスルホキシド67mlに溶解させた後、カリウムシアニド3.0g、塩化アンモニウム1.4g、18−クラウン−6 6.8gを順番に投入した後、80℃で2時間の間撹拌した。反応完了後、反応液にトルエン100mlと水100mlを投入して10分間撹拌した。有機層を分離して1N塩酸水溶液と飽和炭酸水素ナトリウム水溶液で順番に洗浄した後、硫酸ナトリウムで脱水乾燥した後、減圧濃縮して標題の化合物75.4gを得た。水層を分離して硫酸ナトリウムで脱水乾燥した後、減圧濃縮した。濃縮残渣にn−ヘキサン100mlを投入して常温で1時間の間撹拌した。生成された固体を減圧ろ過して、真空乾燥して標題の化合物4.0gを得た。
250mlのフラスコに前記工程c−2で製造した(R)−ベンジル 2−(2,4,5−トリフルオロベンジル)アジリジン−1−カルボキシラート15.78gをジメチルスルホキシド63.2ml、水15.8mlに溶解させた後、シリカゲル7.89gを加えた。反応液にカリウムシアニド6.40gをゆっくり加えた後、50℃で24時間の間撹拌した。反応液を常温に冷却し、ジクロロメタン160mlと水800mlを順番に加えた。有機層を分離して水80mlで2回洗浄した後、硫酸ナトリウムで脱水乾燥した後、減圧濃縮した。濃縮残渣にジイソプロピルエーテル80mlを投入して常温で1時間の間撹拌した。生成された固体を減圧ろ過して、真空乾燥して標題の化合物14.66gを得た。
<工程e−1>(R)−3−(t−ブトキシカルボニルアミノ)−4−(2,4,5−トリフルオロフェニル)ブタノイック酸(化学式2)の製造
250mlのフラスコに前記工程d−1で製造した(R)−t−ブチル 1−シアノ−3−(2,4,5−トリフルオロフェニル)プロパン−2−イルカルバメート2.0gをエチルアルコール:水=1:1の混合溶液20mlに溶解させた後、85%の水酸化カリウム3.4gを加えた後、80℃で12時間の間撹拌した。反応液を常温に冷却した後、シュウ酸二水和物8.0gをゆっくり加えた。反応完了後、エチルアセテート40mlと水20mlを投入して20分間撹拌した。有機層を分離して硫酸マグネシウムで脱水乾燥した後、減圧濃縮した。濃縮残渣をカラムクロマトグラフィー(クロロホルム:メタノール=10:1)で分離した後、減圧濃縮して標題の化合物1.10gを得た。
Mass (M+Na):356
1lのフラスコに前記工程d−2で製造した(R)−ベンジル 1−シアノ−3−(2,4,5−トリフルオロフェニル)プロパン−2−イルカルバメート40gに塩酸80mlを加えて110℃に昇温した後、4時間撹拌した。反応液を常温に冷却した後、飽和炭酸水素ナトリウム水溶液500mlをゆっくり滴下した。滴下完了後、反応液を減圧濃縮して濃縮残渣にメタノール400ml、炭酸水素ナトリウム10.7g、N−(ベンジルオキシカルボニルオキシ)スクシンイミド63.5gを順番どおり加えた。反応液を12時間撹拌した後、減圧濃縮した。濃縮残渣をエチルアセテート200mlで希釈した後、5%炭酸水素ナトリウム水溶液200mlをゆっくり加えて10分間撹拌した。層分離後、水層にクエン酸を加えて反応液のpHを4〜5に調節した。エチルアセテート200mlを加えて10分間撹拌した後、有機層を分離して硫酸ナトリウムで脱水乾燥した後、減圧濃縮した。濃縮残渣をカラムクロマトグラフィー(クロロホルム:メタノール=10:1)で分離した後、減圧濃縮して標題の化合物30.4gを得た。
Mass (M+1):368
工程a’:(S)−メチル 2−ブロモ−3−t−ブトキシプロパノエート(化学式11)の製造
反応基に塩化メチレン686.0lを入れて(S)−メチル 2−ブロモ−3−ヒドロキシプロパノエート85.0kgを投入した後、30分間撹拌した。硫酸1.3kgを反応液にゆっくり加えた後、イソブチレンガスを反応温度20〜35℃を維持して43時間バブリングさせた。反応完了後、炭酸水素ナトリウム20kgを水400Lに溶解した水溶液をゆっくり投入した後、30分撹拌した。有機層を分離して硫酸ナトリウム50kgを加えた後、30分さらに撹拌してろ過した。ろ過液を減圧濃縮して標題の化合物98.7kgを得た。
工程b’:(R)−3−(t−ブトキシメチル)ピペラジン−2−オン(化学式3)の製造
反応器に1,4−ジオキサン691.0lを入れて前記工程a’で製造した(S)−メチル 2−ブロモ−3−t−ブトキシプロパノエート98.7kgを投入して溶解した後、炭酸水素ナトリウム121.4kgとエチレンジアミン55.1lを順番に投入した。内部温度45〜50℃を維持しながら24時間の間撹拌した。反応完了後、常温に冷却し生成した固体をろ過した。1,4−ジオキサン100lで洗浄した後、ろ過液に酢酸20.0kgを投入して1時間の間撹拌した。反応液をろ過(メタノール100lで洗浄)した後、減圧濃縮した。濃縮残渣にイソプロピルエーテル80lと水80lを入れて2回にわたって水層を分離した。水層に塩化メチレン/イソプロパノール(塩化メチレン:イソプロパノール=5:1)混合溶液126lを加えて撹拌した後、有機層を分離した(5回実施)。有機層に硫酸ナトリウム50kgを加えた後、30分間撹拌してろ過した。ろ過液を減圧濃縮して標題の化合物45.2kgを得た。
工程1:t−ブチル(R)−4−[(R)−2−(t−ブトキシメチル)−3−オキソピペラジン−1−イル]−4−オキソ−1−(2,4,5−トリフルオロフェニル)ブタン −2−イルカルバメート(化学式4)の製造
2lのフラスコに前記実施例1で製造した(R)−3−t−ブトキシカルボニルアミノ−4−(2,4,5−トリフルオロフェニル)ブタノイック酸(化学式2)10.0gをトルエン450mlに溶解した後、ビス(2,2’−ベンゾチアゾリル)ジスルフィド13.0g、トリフェニルホスフィン10.2gを加えた後、反応液を0℃に冷却した。反応液を撹拌しながらトリエチルアミン0.8mlをトルエン20mlに溶解した溶液を加えて常温で5時間の間撹拌した。反応液を0℃に冷却した後、前記実施例2で製造した(R)−3−(t−ブトキシメチル)ピペラジン−2−オン(化学式3)5.6gにトルエン40mlに溶解した溶液とピリジン2.4mlをゆっくり加えた。30分後、反応液を常温に昇温させて1時間さらに撹拌した。飽和クエン酸水溶液でpHを2.5になるようにした後、エチルアセテート400mlで希釈した。塩水で2回洗浄して有機層を硫酸マグネシウムで脱水及び濃縮した。残渣をカラムクロマトグラフィーで精製して標題の化合物838mgを得た。
前記工程1で製造したt−ブチル(R)−4−[(R)−2−(t−ブトキシメチル)−3−オキソピペラジン−1−イル]−4−オキソ−1−(2,4,5−トリフルオロフェニル)ブタン−2−イルカルバメート97mgをメタノール3mlに溶解した後、2N−塩酸/ジエチルエーテル2mlを加えて常温で3時間の間撹拌した。反応液を濃縮及び減圧乾燥して泡沫状固体の標題化合物64mgを得た。
Mass (M+1):402
工程1:(R)−4−[(R)−3−アミノ−4−(2,4,5−トリフルオロフェニル)ブタノイル]−3−(t−ブトキシメチル)ピペラジン−2−オン(化学式1)の製造
前記実施例3で得た化学式1の塩酸塩化合物60mgに5%炭酸水素ナトリウム水溶液10mlを加えてジクロロメタン/2−プロパノール(4/1(v/v))混合溶液10mlを加えて2回抽出して有機層を減圧乾燥して固体の標題化合物55mgを得た。
Mass (M+1):402
前記工程1の化合物55mgをアセトン0.56mlに溶解した後、L−酒石酸26mgをエチルアルコール/水(9/1(v/v))0.35mlに溶解した溶液をゆっくり加えて30分間撹拌させた。そこに2−プロパノール0.56mlを再び加えて10分間撹拌した後、ろ過して固体の標題化合物77mgを得た。
Mass (M+1):402
Claims (12)
- 下記のスキーム1に示したとおり、
化学式5の化合物にグリニャール(Grignard)試薬を用いてエポキシ環を開環して化学式6の化合物を製造する工程(工程a)と、
前記化学式6の化合物にアジ化ナトリウムを反応させて化学式7の化合物を製造する工程(工程b)と、
前記化学式7の化合物にトリフェニルホスフィンを反応させて化学式8の化合物を製造する工程(工程c)と、
前記化学式8の化合物を、シアン系列試薬を用いて、アジリジン環を開環して化学式9の化合物を製造する工程(工程d)、及び
前記化学式9の化合物を塩基を用いて加水分解して化学式2の化合物を製造する工程(工程e)とを含む方法で製造されることを特徴とする化学式2で表わされるジペプチジルペプチダーゼ−IV阻害剤中間体の製造方法:
- 前記アミン保護基が、ブトキシカルボニル(Boc)、ベンジルオキシカルボニル(Cbz)、9−フルオレニルメトキシカルボニル(Fmoc)、アセチル、ベンゾイル及びトシルからなる群から選択されることを特徴とする、請求項1に記載のジペプチジルペプチダーゼ−IV阻害剤中間体の製造方法。
- 下記の化学式8で表わされる、請求項1に記載の化学式2の化合物製造時に生成される誘導体:
- 下記の化学式9で表わされる、請求項1に記載の化学式2の化合物製造時に生成される誘導体:
- 下記のスキーム2に示したとおり、
化学式10の化合物のヒドロキシ基にt−ブトキシ基を導入して化学式11の化合物を製造する工程(工程a’)、及び
前記化学式11の化合物をエチレンジアミンと反応させて環化反応を誘導して化学式3の化合物を製造する工程(工程b’)を含む化学式3で表わされるジペプチジルペプチダーゼ−IV阻害剤中間体の製造方法:
- 下記のスキーム3に示したとおり、
反応溶媒下で化学式2の化合物と化学式3の化合物をトリフェニルホスフィン、ビス(2,2’−ベンゾチアゾリル)ジスルフィド及び塩基を用いて反応させてペプチド結合で連結された化学式4の化合物を製造する工程(工程1)、及び
前記工程1で製造した化学式4の化合物のアミン保護基を除去して化学式1の化合物を製造する工程(工程2)を含む化学式1で表わされるジペプチジルペプチダーゼ−IV阻害剤の改良された製造方法:
- 前記反応溶媒が、トルエン、テトラヒドロフラン、塩化メチレン、アセトニトリル及びN,N−ジメチルホルムアミドからなる群から選択されることを特徴とする、請求項6に記載のジペプチジルペプチダーゼ−IV阻害剤の改良された製造方法。
- 前記塩基が、N−メチルモルホリン、イソプロピルエチルアミン、トリエチルアミン及びピリジンからなる群から選択される1種以上であることを特徴とする、請求項6に記載のジペプチジルペプチダーゼ−IV阻害剤の改良された製造方法。
- 前記工程1の反応が、−20〜80℃で遂行されることを特徴とする、請求項6に記載のジペプチジルペプチダーゼ−IV阻害剤の改良された製造方法。
- 前記アミン保護基が、ブトキシカルボニル(Boc)、ベンジルオキシカルボニル(Cbz)、9−フルオレニルメトキシカルボニル(Fmoc)、アセチル、ベンゾイル及びトシルからなる群から選択されることを特徴とする、請求項6に記載のジペプチジルペプチダーゼ−IV阻害剤の改良された製造方法。
- 前記工程2は、アミン保護基がブトキシカルボニル(Boc)の場合、前記化学式4の化合物をトリフルオロ酢酸/ジクロロメタン、エチルアセテート/塩化水素、ジエチルエーテル/塩化水素、塩化水素/ジクロロメタンまたはメタノール/塩化水素と反応させて保護基を除去することを特徴とする、請求項6に記載のジペプチジルペプチダーゼ−IV阻害剤の改良された製造方法。
- 前記工程2は、アミン保護基がベンジルオキシカルボニル(Cbz)の場合、前記化学式4の化合物をパラジウム/カーボン存在下で水素と反応させることで保護基を除去することを特徴とする、請求項6に記載のジペプチジルペプチダーゼ−IV阻害剤の改良された製造方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2009-0027105 | 2009-03-30 | ||
KR20090027105 | 2009-03-30 | ||
PCT/KR2010/001947 WO2010114291A2 (ko) | 2009-03-30 | 2010-03-30 | 디펩티딜 펩티다아제-ⅳ 저해제 및 중간체의 개량된 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012522044A true JP2012522044A (ja) | 2012-09-20 |
JP5475863B2 JP5475863B2 (ja) | 2014-04-16 |
Family
ID=42828845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012503324A Active JP5475863B2 (ja) | 2009-03-30 | 2010-03-30 | ジペプチジルペプチダーゼ−iv阻害剤及び中間体の改良された製造方法 |
Country Status (17)
Country | Link |
---|---|
US (2) | US20120016125A1 (ja) |
EP (2) | EP2669265A3 (ja) |
JP (1) | JP5475863B2 (ja) |
KR (1) | KR101152899B1 (ja) |
CN (2) | CN103922971B (ja) |
AU (1) | AU2010232085B2 (ja) |
BR (1) | BRPI1014087B1 (ja) |
CA (2) | CA2800245C (ja) |
ES (1) | ES2523995T3 (ja) |
HK (1) | HK1168085A1 (ja) |
IL (2) | IL215290A (ja) |
MX (2) | MX2011010204A (ja) |
NZ (2) | NZ595542A (ja) |
PL (1) | PL2415753T3 (ja) |
RU (1) | RU2499792C2 (ja) |
SG (1) | SG174974A1 (ja) |
WO (1) | WO2010114291A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019534299A (ja) * | 2016-11-04 | 2019-11-28 | エスティー ファーム カンパニー リミテッド | (s)−n1−(2−アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の製造方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101290029B1 (ko) | 2011-01-20 | 2013-07-30 | 에스티팜 주식회사 | 시타글립틴의 중간체 제조방법 |
CN103910655A (zh) * | 2014-04-11 | 2014-07-09 | 太原理工大学 | 一种氮杂环丙烷化合物开环的方法 |
KR101709127B1 (ko) * | 2015-06-16 | 2017-02-22 | 경동제약 주식회사 | Dpp-iv 억제제의 제조를 위한 신규 중간체, 이의 제조방법 및 이를 이용한 dpp-iv 억제제의 제조방법 |
CN105017081B (zh) * | 2015-07-08 | 2017-03-08 | 和鼎(南京)医药技术有限公司 | 一种西他列汀中间体的制备方法 |
CN113816887A (zh) * | 2021-08-31 | 2021-12-21 | 华中科技大学 | 一种氮杂环丙烷类化合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11310568A (ja) * | 1998-04-30 | 1999-11-09 | Nissan Chem Ind Ltd | ペンタン酸アミド類 |
JP2005206492A (ja) * | 2004-01-21 | 2005-08-04 | Sankyo Co Ltd | スルホンアミド化合物 |
WO2008130151A1 (en) * | 2007-04-19 | 2008-10-30 | Dong-A Pharm. Co., Ltd. | Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002310465B2 (en) | 2001-06-20 | 2006-06-15 | Merck & Co., Inc. | Dipeptidyl peptidase inhibitors for the treatment of diabetes |
UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
PL372316A1 (en) * | 2002-02-28 | 2005-07-11 | Prosidion Limited | Glutaminyl based dpiv inhibitors |
EP1490335B1 (en) | 2002-03-25 | 2007-09-19 | Merck & Co., Inc. | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
ATE451369T1 (de) | 2002-07-15 | 2009-12-15 | Merck & Co Inc | Piperidinopyrimidindipeptidylpeptidaseinhibitor n zur behandlung von diabetes |
WO2004032836A2 (en) | 2002-10-07 | 2004-04-22 | Merck & Co., Inc. | Antidiabetic beta-amino heterocylcic dipeptidyl peptidase inhibitors |
WO2004083173A2 (en) * | 2003-03-18 | 2004-09-30 | Merck & Co., Inc. | Ketopiperazine derivatives as bradykinin antagonists |
WO2004087650A2 (en) | 2003-03-27 | 2004-10-14 | Merck & Co. Inc. | Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors |
ATE417832T1 (de) | 2003-07-31 | 2009-01-15 | Merck & Co Inc | Hexahydrodiazepinone als inhibitoren des dipeptidylpeptidase-iv zur behandlung bzw. prävention von diabetes |
WO2006098342A1 (en) * | 2005-03-16 | 2006-09-21 | Astellas Pharma Inc. | Piperazinyl compounds |
EP1702916A1 (en) | 2005-03-18 | 2006-09-20 | Santhera Pharmaceuticals (Schweiz) GmbH | DPP-IV inhibitors |
WO2007063928A1 (ja) | 2005-11-30 | 2007-06-07 | Toray Industries, Inc. | 新規な非環状アミンカルボキシアミド誘導体及びその塩 |
US20090156465A1 (en) | 2005-12-30 | 2009-06-18 | Sattigeri Jitendra A | Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
WO2008028662A1 (en) | 2006-09-07 | 2008-03-13 | Santhera Pharmaceuticals (Schweiz) Ag | N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment of type 2 diabetes mellitus |
KR100848491B1 (ko) | 2007-01-16 | 2008-07-28 | 영진약품공업주식회사 | 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법 |
DE102007014286A1 (de) * | 2007-03-19 | 2008-09-25 | Universität Tübingen | Fluorsubstituierte Amphetamine und Amphetaminderivate und deren Verwendung |
CN100516014C (zh) * | 2007-04-04 | 2009-07-22 | 浙江永太科技股份有限公司 | 2,4,5-三氟苯乙酸的制备方法 |
US7820666B2 (en) * | 2007-05-08 | 2010-10-26 | Concert Pharmaceuticals, Inc. | Tetrahydrotriazolopyrazine derivatives and uses thereof |
KR20090027105A (ko) | 2007-09-11 | 2009-03-16 | 주식회사 하이닉스반도체 | 듀얼 게이트 절연막 형성방법 |
ES2571443T3 (es) * | 2009-03-30 | 2016-05-25 | Dong A St Co Ltd | Método mejorado para la fabricación de un inhibidor de la dipeptidil peptidasa-IV y de un intermedio |
-
2010
- 2010-03-30 NZ NZ595542A patent/NZ595542A/xx unknown
- 2010-03-30 MX MX2011010204A patent/MX2011010204A/es active IP Right Grant
- 2010-03-30 CA CA2800245A patent/CA2800245C/en active Active
- 2010-03-30 MX MX2012015019A patent/MX344498B/es unknown
- 2010-03-30 US US13/259,699 patent/US20120016125A1/en not_active Abandoned
- 2010-03-30 EP EP13175341.0A patent/EP2669265A3/en not_active Withdrawn
- 2010-03-30 SG SG2011070919A patent/SG174974A1/en unknown
- 2010-03-30 AU AU2010232085A patent/AU2010232085B2/en active Active
- 2010-03-30 CN CN201410104035.XA patent/CN103922971B/zh active Active
- 2010-03-30 PL PL10759016T patent/PL2415753T3/pl unknown
- 2010-03-30 RU RU2011141208/04A patent/RU2499792C2/ru active
- 2010-03-30 ES ES10759016.8T patent/ES2523995T3/es active Active
- 2010-03-30 CA CA2756893A patent/CA2756893C/en active Active
- 2010-03-30 BR BRPI1014087-5A patent/BRPI1014087B1/pt active IP Right Grant
- 2010-03-30 NZ NZ608028A patent/NZ608028A/en unknown
- 2010-03-30 JP JP2012503324A patent/JP5475863B2/ja active Active
- 2010-03-30 CN CN201080015010.2A patent/CN102378751B/zh active Active
- 2010-03-30 EP EP10759016.8A patent/EP2415753B1/en active Active
- 2010-03-30 KR KR1020100028477A patent/KR101152899B1/ko active Protection Beyond IP Right Term
- 2010-03-30 WO PCT/KR2010/001947 patent/WO2010114291A2/ko active Application Filing
-
2011
- 2011-09-21 IL IL215290A patent/IL215290A/en active IP Right Grant
-
2012
- 2012-09-10 HK HK12108817.0A patent/HK1168085A1/xx unknown
-
2014
- 2014-09-02 IL IL234436A patent/IL234436A/en active IP Right Grant
- 2014-10-03 US US14/506,025 patent/US9249109B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11310568A (ja) * | 1998-04-30 | 1999-11-09 | Nissan Chem Ind Ltd | ペンタン酸アミド類 |
JP2005206492A (ja) * | 2004-01-21 | 2005-08-04 | Sankyo Co Ltd | スルホンアミド化合物 |
WO2008130151A1 (en) * | 2007-04-19 | 2008-10-30 | Dong-A Pharm. Co., Ltd. | Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019534299A (ja) * | 2016-11-04 | 2019-11-28 | エスティー ファーム カンパニー リミテッド | (s)−n1−(2−アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の製造方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5475863B2 (ja) | ジペプチジルペプチダーゼ−iv阻害剤及び中間体の改良された製造方法 | |
JP5475864B2 (ja) | ジペプチジルペプチダーゼ−iv阻害剤及び中間体の改良された製造方法 | |
AU2013200419B2 (en) | Improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate | |
JP5108888B2 (ja) | 光学活性なn−(ハロプロピル)アミノ酸誘導体の製造方法 | |
US20100063280A1 (en) | Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds | |
JP2006225344A (ja) | 2−アシルアミノメチル−3,4−ジヒドロキシピロリジン型酵素阻害剤 | |
WO2010092286A1 (fr) | Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130612 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130625 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130918 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130926 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131225 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140128 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140206 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5475863 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |